{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:25:52Z","timestamp":1792891552008,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10549-023-07205-6","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T13:02:35Z","timestamp":1704718955000},"page":"561-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors"],"prefix":"10.1007","volume":"204","author":[{"given":"Ching-Yuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Hincapie-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coy D.","family":"Heldermon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vakaramoko","family":"Diaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6590-4770","authenticated-orcid":false,"given":"Wei-Hsuan","family":"Lo-Ciganic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"7205_CR1","unstructured":"Substance abuse center for behavioral health statistics and quality (2021) Results from the 2020 National Survey on Drug Use and Health: Detailed Tables: SAMHSA. https:\/\/www.samhsa.gov\/data\/release\/2020-national-survey-drug-use-and-health-nsduh-releases#detailed-tables"},{"key":"7205_CR2","unstructured":"Centers for Disease Control and Prevention. Drug overdose. Opioid over dose. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/opioid-overdose.html"},{"key":"7205_CR3","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics (2022) U.S. overdose deaths in 2021 increased half as much as in 2020\u2014but are still up 15%. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/202205.htm"},{"issue":"15","key":"7205_CR4","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain-united states, 2016. JAMA 315(15):1624\u20131645","journal-title":"JAMA"},{"issue":"9","key":"7205_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","volume":"64","author":"LJ Paulozzi","year":"2015","unstructured":"Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM (2015) Controlled substance prescribing patterns-prescription behavior surveillance system, eight states, 2013. MMWR Surveill Summ 64(9):1\u201314","journal-title":"MMWR Surveill Summ"},{"issue":"2s","key":"7205_CR6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.36076\/ppj.2017.s92","volume":"20","author":"L Manchikanti","year":"2017","unstructured":"Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, Blank S, Pampati V, Abdi S, Grider JS et al (2017) Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines. Pain Physician 20(2s):S3-s92","journal-title":"Pain Physician"},{"key":"7205_CR7","doi-asserted-by":"publisher","unstructured":"Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E et al (2019) Adult cancer pain, Version 3.2019, NCCN clinical practice guidelines in oncology. J Nat Comp Cancer Netw: JNCCN 17(8):977\u20131007. https:\/\/doi.org\/10.6004\/jnccn.2019.0038","DOI":"10.6004\/jnccn.2019.0038"},{"key":"7205_CR8","doi-asserted-by":"publisher","unstructured":"Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M et al (2020) NCCN guidelines insights: survivorship, Version 2.2020. J Nat Comp Cancer Netw: JNCCN 18(8):1016\u20131023. https:\/\/doi.org\/10.6004\/jnccn.2020.0037","DOI":"10.6004\/jnccn.2020.0037"},{"issue":"8","key":"7205_CR9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1200\/JOP.2016.014837","volume":"12","author":"JA Paice","year":"2016","unstructured":"Paice JA, Lacchetti C, Bruera E (2016) Management of chronic pain in survivors of adult cancers: ASCO clinical practice guideline summary. J Oncol Pract 12(8):757\u2013762","journal-title":"J Oncol Pract"},{"issue":"13","key":"7205_CR10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","volume":"305","author":"AS Bohnert","year":"2011","unstructured":"Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC (2011) Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305(13):1315\u20131321","journal-title":"JAMA"},{"issue":"9","key":"7205_CR11","doi-asserted-by":"crossref","first-page":"e2016858","DOI":"10.1001\/jamanetworkopen.2020.16858","volume":"3","author":"AN Winn","year":"2020","unstructured":"Winn AN, Check DK, Farkas A, Fergestrom NM, Neuner JM, Roberts AW (2020) Association of current opioid use with serious adverse events among older adult survivors of breast cancer. JAMA Netw Open 3(9):e2016858\u2013e2016858","journal-title":"JAMA Netw Open"},{"issue":"4","key":"7205_CR12","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/j.jpainsymman.2021.10.015","volume":"63","author":"DK Check","year":"2022","unstructured":"Check DK, Avecilla RAV, Mills C, Dinan MA, Kamal AH, Murphy B, Rezk S, Winn A, Oeffinger KC (2022) Opioid prescribing and use among cancer survivors: a mapping review of observational and intervention studies. J Pain Symptom Manage 63(4):e397\u2013e417","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"7205_CR13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/jgs.15945","volume":"67","author":"R Shah","year":"2019","unstructured":"Shah R, Chou LN, Kuo YF, Raji MA (2019) Long-term opioid therapy in older cancer survivors: a retrospective cohort study. J Am Geriatr Soc 67(5):945\u2013952","journal-title":"J Am Geriatr Soc"},{"issue":"36","key":"7205_CR14","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","volume":"35","author":"JS Lee","year":"2017","unstructured":"Lee JS, Hu HM, Edelman AL, Brummett CM, Englesbe MJ, Waljee JF, Smerage JB, Griggs JJ, Nathan H, Jeruss JS et al (2017) New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol 35(36):4042\u20134049","journal-title":"J Clin Oncol"},{"issue":"12","key":"7205_CR15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.18.00938","volume":"37","author":"T Salz","year":"2019","unstructured":"Salz T, Lavery JA, Lipitz-Snyderman AN, Boudreau DM, Moryl N, Gillespie EF, Korenstein D (2019) Trends in opioid use among older survivors of colorectal, lung, and breast cancers. J Clin Oncol 37(12):1001\u20131011","journal-title":"J Clin Oncol"},{"issue":"7","key":"7205_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.6004\/jnccn.2019.0034","volume":"17","author":"T Sanft","year":"2019","unstructured":"Sanft T, Denlinger CS, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N et al (2019) NCCN guidelines insights: survivorship, version 2.2019. J Natl Compr Canc Netw 17(7):784\u2013794","journal-title":"J Natl Compr Canc Netw"},{"key":"7205_CR17","unstructured":"Surveillance, Epidemiology, and End Results Program National Center for Health Statistics (2019) Cancer Stat Facts: Female breast cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"issue":"7","key":"7205_CR18","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE (2018) Group-based multi-trajectory modeling. Stat Methods Med Res 27(7):2015\u20132023","journal-title":"Stat Methods Med Res"},{"key":"7205_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL (2010) Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 6:109\u2013138","journal-title":"Annu Rev Clin Psychol"},{"issue":"8 Suppl","key":"7205_CR20","first-page":"IV","volume":"40","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV\u20133-IV-18","journal-title":"Med Care"},{"issue":"8","key":"7205_CR21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00005650-199308000-00006","volume":"31","author":"AL Potosky","year":"1993","unstructured":"Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG (1993) Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31(8):732\u2013748","journal-title":"Med Care"},{"key":"7205_CR22","unstructured":"Division of Cancer Control and Population Sciences (2023) SEER-Medicare linked data resource. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/"},{"key":"7205_CR23","unstructured":"Health Resources and Services Administration (2022) Area health resources files. https:\/\/data.hrsa.gov\/"},{"issue":"7","key":"7205_CR24","volume":"15","author":"WH Lo-Ciganic","year":"2020","unstructured":"Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Kwoh CK, Donohue JM, Gordon AJ, Cochran G, Malone DC, Kuza CC et al (2020) Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: a prognostic study. PLoS ONE 15(7):e0235981","journal-title":"PLoS ONE"},{"key":"7205_CR25","unstructured":"Medications for substance use disorders, medications, counseling, and related conditions, buprenorphine [https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/medications-counseling-related-conditions\/buprenorphine]"},{"issue":"11","key":"7205_CR26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2016.0151","volume":"14","author":"A Syrowatka","year":"2016","unstructured":"Syrowatka A, Chang SL, Tamblyn R, Mayo NE, Meguerditchian AN (2016) Psychotropic and opioid medication use in older patients with breast cancer across the care trajectory: a population-based cohort study. J Natl Compr Canc Netw 14(11):1412\u20131419","journal-title":"J Natl Compr Canc Netw"},{"key":"7205_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/add.15189","author":"L Zhou","year":"2020","unstructured":"Zhou L, Bhattacharjee S, Kwoh CK, Tighe PJ, Reisfield GM, Malone DC, Slack M, Wilson DL, Chang CY, Lo-Ciganic WH (2020) Dual-trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study. Addiction. https:\/\/doi.org\/10.1111\/add.15189","journal-title":"Addiction"},{"key":"7205_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"G Schwarz","year":"1978","unstructured":"Schwarz G (1978) Estimating the dimension of a model. Ann Statis 6:461\u2013464","journal-title":"Ann Statis"},{"issue":"6","key":"7205_CR29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165(6):710\u2013718","journal-title":"Am J Epidemiol"},{"issue":"7","key":"7205_CR30","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/add.15857","volume":"117","author":"WH Lo-Ciganic","year":"2022","unstructured":"Lo-Ciganic WH, Hincapie-Castillo J, Wang T, Ge Y, Jones BL, Huang JL, Chang CY, Wilson DL, Lee JK, Reisfield GM et al (2022) Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models. Addiction 117(7):1982\u20131997","journal-title":"Addiction"},{"issue":"3","key":"7205_CR31","doi-asserted-by":"crossref","first-page":"e190968","DOI":"10.1001\/jamanetworkopen.2019.0968","volume":"2","author":"W-H Lo-Ciganic","year":"2019","unstructured":"Lo-Ciganic W-H, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC et al (2019) Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescriptions. JAMA Netw Open 2(3):e190968\u2013e190968","journal-title":"JAMA Netw Open"},{"issue":"5","key":"7205_CR32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/pds.4157","volume":"26","author":"CA Green","year":"2017","unstructured":"Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM (2017) Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf 26(5):509\u2013517","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"7205_CR33","volume":"2","author":"WH Lo-Ciganic","year":"2019","unstructured":"Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC et al (2019) Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescriptions. JAMA Netw Open 2(3):e190968","journal-title":"JAMA Netw Open"},{"issue":"4","key":"7205_CR34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/pm\/pnx002","volume":"19","author":"LR Gauthier","year":"2018","unstructured":"Gauthier LR, Dworkin RH, Warr D, Pillai Riddell R, Macpherson AK, Rodin G, Zimmermann C, Lawrence Librach S, Moore M, Shepherd FA et al (2018) Age-related patterns in cancer pain and its psychosocial impact: investigating the role of variability in physical and mental health quality of life. Pain Med 19(4):658\u2013676","journal-title":"Pain Med"},{"issue":"4","key":"7205_CR35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jpainsymman.2015.11.012","volume":"51","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Dev R, Reddy A, Hui D, Tanco K, Park M, Liu D, Williams J, Bruera E (2016) Association between tobacco use, symptom expression, and alcohol and illicit drug use in advanced cancer patients. J Pain Symptom Manage 51(4):762\u2013768","journal-title":"J Pain Symptom Manage"},{"issue":"21","key":"7205_CR36","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.30839","volume":"123","author":"R Sutradhar","year":"2017","unstructured":"Sutradhar R, Lokku A, Barbera L (2017) Cancer survivorship and opioid prescribing rates: a population-based matched cohort study among individuals with and without a history of cancer. Cancer 123(21):4286\u20134293","journal-title":"Cancer"},{"issue":"9","key":"7205_CR37","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/lary.27791","volume":"129","author":"N Silver","year":"2019","unstructured":"Silver N, Dourado J, Hitchcock K, Fullerton A, Fredenburg K, Dziegielewski P, Danan D, Tighe P, Morris C, Amdur R et al (2019) Chronic opioid use in patients undergoing treatment for oropharyngeal cancer. Laryngoscope 129(9):2087\u20132093","journal-title":"Laryngoscope"},{"issue":"5","key":"7205_CR38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/j.pain.0000000000000859","volume":"158","author":"RM Sipila","year":"2017","unstructured":"Sipila RM, Haasio L, Meretoja TJ, Ripatti S, Estlander AM, Kalso EA (2017) Does expecting more pain make it more intense? Factors associated with the first week pain trajectories after breast cancer surgery. Pain 158(5):922\u2013930","journal-title":"Pain"},{"issue":"2","key":"7205_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.athoracsur.2018.08.057","volume":"107","author":"AA Brescia","year":"2019","unstructured":"Brescia AA, Harrington CA, Mazurek AA, Ward ST, Lee JSJ, Hu HM, Brummett CM, Waljee JF, Lagisetty PA, Lagisetty KH (2019) Factors associated with new persistent opioid usage after lung resection. Ann Thorac Surg 107(2):363\u2013368","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"7205_CR40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpainsymman.2019.02.024","volume":"58","author":"L Barbera","year":"2019","unstructured":"Barbera L, Sutradhar R, Howell D, Corn E, O\u2019Brien MA, Seow H, Dudgeon D, Atzema C, Earle CC, DeAngelis C et al (2019) Factors associated with opioid use in long-term cancer survivors. J Pain Symptom Manage 58(1):100-107.e102","journal-title":"J Pain Symptom Manage"},{"issue":"23","key":"7205_CR41","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1002\/cncr.30240","volume":"122","author":"JA Arthur","year":"2016","unstructured":"Arthur JA, Edwards T, Lu Z, Reddy S, Hui D, Wu J, Liu D, Williams JL, Bruera E (2016) Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic. Cancer 122(23):3732\u20133739","journal-title":"Cancer"},{"issue":"11","key":"7205_CR42","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1007\/s00520-017-3774-9","volume":"25","author":"R Chow","year":"2017","unstructured":"Chow R, Saunders K, Burke H, Belanger A, Chow E (2017) Needs assessment of primary care physicians in the management of chronic pain in cancer survivors. Support Care Cancer 25(11):3505\u20133514","journal-title":"Support Care Cancer"},{"issue":"7","key":"7205_CR43","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1245\/s10434-018-6466-x","volume":"25","author":"JS Lee","year":"2018","unstructured":"Lee JS, Parashar V, Miller JB, Bremmer SM, Vu JV, Waljee JF, Dossett LA (2018) Opioid prescribing after curative-intent surgery: a qualitative study using the theoretical domains framework. Ann Surg Oncol 25(7):1843\u20131851","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7205_CR44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-017-4348-8","volume":"165","author":"X Tan","year":"2017","unstructured":"Tan X, Camacho TF, LeBaron VT, Blackhall LJ, Balkrishnan R (2017) Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens. Breast Cancer Res Treat 165(2):455\u2013465","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"7205_CR45","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00520-019-04828-8","volume":"27","author":"B George","year":"2019","unstructured":"George B, Minello C, Allano G, Maindet C, Burnod A, Lemaire A (2019) Opioids in cancer-related pain: current situation and outlook. Support Care Cancer 27(8):3105\u20133118","journal-title":"Support Care Cancer"},{"issue":"18","key":"7205_CR46","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/ajhp\/zxz146","volume":"76","author":"MC Bicket","year":"2019","unstructured":"Bicket MC, Brat GA, Hutfless S, Wu CL, Nesbit SA, Alexander GC (2019) Optimizing opioid prescribing and pain treatment for surgery: review and conceptual framework. Am J Health Syst Pharm 76(18):1403\u20131412","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"7205_CR47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jso.25636","volume":"120","author":"BL Murphy","year":"2019","unstructured":"Murphy BL, Thiels CA, Hanson KT, McLaughlin S, Jakub JW, Gray RJ, Ubl DS, Habermann EB (2019) Pain and opioid prescriptions vary by procedure after breast surgery. J Surg Oncol 120(4):593\u2013602","journal-title":"J Surg Oncol"},{"issue":"3","key":"7205_CR48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpain.2017.11.001","volume":"19","author":"N Moryl","year":"2018","unstructured":"Moryl N, Dave V, Glare P, Bokhari A, Malhotra VT, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R et al (2018) Patient-reported outcomes and opioid use by outpatient cancer patients. J Pain 19(3):278\u2013290","journal-title":"J Pain"},{"issue":"3","key":"7205_CR49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0194599818778276","volume":"160","author":"A Saraswathula","year":"2019","unstructured":"Saraswathula A, Chen MM, Mudumbai SC, Whittemore AS, Divi V (2019) Persistent postoperative opioid use in older head and neck cancer patients. Otolaryngol Head Neck Surg 160(3):380\u2013387","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"19","key":"7205_CR50","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1002\/cncr.31670","volume":"124","author":"S Yennurajalingam","year":"2018","unstructured":"Yennurajalingam S, Edwards T, Arthur JA, Lu Z, Najera J, Nguyen K, Manju J, Kuriakose L, Wu J, Liu D et al (2018) Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center. Cancer 124(19):3942\u20133949","journal-title":"Cancer"},{"issue":"1","key":"7205_CR51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/add.13543","volume":"112","author":"M Cerda","year":"2017","unstructured":"Cerda M, Gaidus A, Keyes KM, Ponicki W, Martins S, Galea S, Gruenewald P (2017) Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas. Addiction 112(1):103\u2013112","journal-title":"Addiction"},{"issue":"10","key":"7205_CR52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/AJP.0000000000000472","volume":"33","author":"DH Kim","year":"2017","unstructured":"Kim DH, Park JY, Karm MH, Bae HY, Lee JY, Soo Ahn H, Lee K, Leem JG (2017) Smoking may increase postoperative opioid consumption in patients who underwent distal gastrectomy with gastroduodenostomy for early stomach cancer: a retrospective analysis. Clin J Pain 33(10):905\u2013911","journal-title":"Clin J Pain"},{"issue":"3","key":"7205_CR53","doi-asserted-by":"crossref","first-page":"234","DOI":"10.22365\/jpsych.2017.283.234","volume":"28","author":"GI Moussas","year":"2017","unstructured":"Moussas GI, Papadopoulou AG (2017) Substance abuse and cancer. Psychiatriki 28(3):234\u2013241","journal-title":"Psychiatriki"},{"issue":"1","key":"7205_CR54","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12885-018-4478-3","volume":"18","author":"E Lucenteforte","year":"2018","unstructured":"Lucenteforte E, Vagnoli L, Pugi A, Crescioli G, Lombardi N, Bonaiuti R, Arico M, Giglio S, Messeri A, Mugelli A et al (2018) A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study. BMC Cancer 18(1):568","journal-title":"BMC Cancer"},{"issue":"Suppl 1","key":"7205_CR55","first-page":"E1521","volume":"38","author":"S Alfieri","year":"2016","unstructured":"Alfieri S, Ripamonti CI, Marceglia S, Orlandi E, Iacovelli NA, Granata R, Cavallo A, Pozzi P, Boffi R, Bergamini C et al (2016) Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer. Head Neck 38(Suppl 1):E1521-1527","journal-title":"Head Neck"},{"key":"7205_CR56","doi-asserted-by":"crossref","unstructured":"Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C et al (2022) Breast cancer, Version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20(6):691\u2013722","DOI":"10.6004\/jnccn.2022.0030"},{"issue":"10","key":"7205_CR57","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1080\/03007995.2019.1615422","volume":"35","author":"RK Goyal","year":"2019","unstructured":"Goyal RK, Carter GC, Nagar SP, Smyth EN, Price GL, Huang YJ, Li L, Davis KL, Kaye JA (2019) Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+\/HER2- metastatic breast cancer. Curr Med Res Opin 35(10):1699\u20131710","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"7205_CR58","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","volume":"53","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258\u20131267","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"7205_CR59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AJP.0000000000000011","volume":"30","author":"AS Bohnert","year":"2014","unstructured":"Bohnert AS, Ilgen MA, Trafton JA, Kerns RD, Eisenberg A, Ganoczy D, Blow FC (2014) Trends and regional variation in opioid overdose mortality among veterans health administration patients, fiscal year 2001 to 2009. Clin J Pain 30(7):605\u2013612","journal-title":"Clin J Pain"},{"issue":"3","key":"7205_CR60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/aje\/kwg115","volume":"158","author":"MS Cepeda","year":"2003","unstructured":"Cepeda MS, Boston R, Farrar JT, Strom BL (2003) Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158(3):280\u2013287","journal-title":"Am J Epidemiol"},{"key":"7205_CR61","unstructured":"Guo S, Fraser MW (2014) Propensity score analysis: statistical methods and applications. Thousand Oaks, California"},{"issue":"4","key":"7205_CR62","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1177\/0962280215584401","volume":"26","author":"PC Austin","year":"2017","unstructured":"Austin PC, Stuart EA (2017) The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes. Stat Methods Med Res 26(4):1654\u20131670","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"7205_CR63","first-page":"604","volume":"6","author":"MA Brookhart","year":"2013","unstructured":"Brookhart MA, Wyss R, Layton JB, St\u00fcrmer T (2013) Propensity score methods for confounding control in nonexperimental research. Circulation 6(5):604\u2013611","journal-title":"Circulation"},{"issue":"7","key":"7205_CR64","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","volume":"172","author":"T St\u00fcrmer","year":"2010","unstructured":"St\u00fcrmer T, Rothman KJ, Avorn J, Glynn RJ (2010) Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2013a simulation study. Am J Epidemiol 172(7):843\u2013854","journal-title":"Am J Epidemiol"},{"issue":"3","key":"7205_CR65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399\u2013424","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"7205_CR66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Kim HJ, Lonjon G, Zhu Y (2019) Balance diagnostics after propensity score matching. Ann Transl Med 7(1):16","journal-title":"Ann Transl Med"},{"issue":"7","key":"7205_CR67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","volume":"173","author":"MJ Funk","year":"2011","unstructured":"Funk MJ, Westreich D, Wiesen C, St\u00fcrmer T, Brookhart MA, Davidian M (2011) Doubly robust estimation of causal effects. Am J Epidemiol 173(7):761\u2013767","journal-title":"Am J Epidemiol"},{"key":"7205_CR68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515\u2013526","journal-title":"Biometrika"},{"issue":"8","key":"7205_CR69","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-11-2097","volume":"18","author":"JJ Dignam","year":"2012","unstructured":"Dignam JJ, Zhang Q, Kocherginsky M (2012) The use and interpretation of competing risks regression models. Clin Cancer Res 18(8):2301\u20132308","journal-title":"Clin Cancer Res"},{"issue":"4","key":"7205_CR70","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P (2017) Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 167(4):268\u2013274","journal-title":"Ann Intern Med"},{"issue":"3","key":"7205_CR71","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00001648-199005000-00010","volume":"1","author":"WD Flanders","year":"1990","unstructured":"Flanders WD, Khoury MJ (1990) Indirect assessment of confounding: graphic description and limits on effect of adjusting for covariates. Epidemiology 1(3):239\u2013246","journal-title":"Epidemiology"},{"issue":"5","key":"7205_CR72","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/EDE.0000000000001381","volume":"32","author":"RF MacLehose","year":"2021","unstructured":"MacLehose RF, Ahern TP, Lash TL, Poole C, Greenland S (2021) The importance of making assumptions in bias analysis. Epidemiology 32(5):617\u2013624","journal-title":"Epidemiology"},{"issue":"2","key":"7205_CR73","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1037\/0012-1649.44.2.422","volume":"44","author":"A Haviland","year":"2008","unstructured":"Haviland A, Nagin DS, Rosenbaum PR, Tremblay RE (2008) Combining group-based trajectory modeling and propensity score matching for causal inferences in nonexperimental longitudinal data. Dev Psychol 44(2):422\u2013436","journal-title":"Dev Psychol"},{"issue":"1","key":"7205_CR74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MLR.0000000000001019","volume":"57","author":"AN Winn","year":"2019","unstructured":"Winn AN, Fergestrom NM, Neuner JM (2019) Using group-based trajectory models and propensity score weighting to detect heterogeneous treatment effects: the case study of generic hormonal therapy for women with breast cancer. Med Care 57(1):85\u201393","journal-title":"Med Care"},{"issue":"3","key":"7205_CR75","first-page":"44","volume":"39","author":"G Suwanee","year":"2014","unstructured":"Suwanee G (2014) Overview of adult outpatient cancer pain management. US Pharm 39(3):44\u201347","journal-title":"US Pharm"},{"issue":"6","key":"7205_CR76","first-page":"E603","volume":"21","author":"A Patwardhan","year":"2018","unstructured":"Patwardhan A, Matika R, Gordon J, Singer B, Salloum M, Ibrahim M (2018) Exploring the role of chronic pain clinics: potential for opioid reduction. Pain Physician 21(6):E603-e610","journal-title":"Pain Physician"},{"issue":"4","key":"7205_CR77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/djaa122","volume":"113","author":"AW Roberts","year":"2021","unstructured":"Roberts AW, Eiffert S, Wulff-Burchfield EM, Dusetzina SB, Check DK (2021) Opioid use disorder and overdose in older adults with breast, colorectal, or prostate cancer. J Natl Cancer Inst 113(4):425\u2013433","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"7205_CR78","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1001\/jama.2008.793","volume":"300","author":"AT McLellan","year":"2008","unstructured":"McLellan AT, Turner B (2008) Prescription opioids, overdose deaths, and physician responsibility. JAMA 300(22):2672\u20132673","journal-title":"JAMA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07205-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T15:21:36Z","timestamp":1711120896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07205-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7205"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07205-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2587997\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Lo-Ciganic reported receiving grants from the National Institute on Drug Abuse, the National Institute on Aging, the National Institute of Mental Health, Merck Sharp & Dohme, Bristol Myers Squibb, the Richard King Mellon Foundation at the University of Pittsburgh, the Clinical and Translational Science Institute of the University of Florida, the Pharmaceutical Research and Manufacturers of America Foundation, and the US Department of Veterans Affairs outside the submitted work; and having a patent pending for U1195.70174US00. Dr Park reported receiving grants from Bristol-Myers Squibb\/Pfizer Alliance American Thrombosis Investigator Initiated Research Program outside the submitted work. Dr Hincapie-Castillo reported receiving grants from Merck & Co outside the submitted work. Ms Wilson reported receiving grants from the National Institute on Drug Abuse, the National Institute on Aging, Merck Sharp & Dohme, and Bristol Myers Squibb outside the submitted work; and serving as an editorial board member for the <i>Journal of Pharmacy Technology<\/i>. Dr Chang's contributions to this manuscript were made while at the University of Florida College of Pharmacy. Dr Chang is currently employed by Vertex Pharmaceuticals, Inc. Vertex did not fund or have any involvement in this study or publication. Dr Diaby is currently employed by Otsuka, Inc. Otsuka did not fund or have any involvement in this study or publication. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}